Form 4 for STIM Neuronetics, Inc.
Accepted 2022-10-24 00:00:00 ET · period of report 2022-10-20 · accession 0001062993-22-021053 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-24 | 2022-10-20 | STIM | Sullivan Keith J | Pres, CEO, Dir | M - OptEx | $1.98 | +100.0K | 951.0K | +12% | +$198.0K |
| D | 2022-10-24 | 2022-10-20 | STIM | Sullivan Keith J | Pres, CEO, Dir | M - OptEx | $0.00 | -100.0K | 900.0K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-20 | M | A | 100,000 | $1.98 | 950,999 | D | — | — | |
| 2 | Derivative | Employee Stock Option (right to buy) | 2022-10-20 | M | D | 100,000 | $0.00 | 900,000 | D | $1.98 · — to 2030-07-14 | 100,000 Common Stock | (F1) Twenty-five percent (25%) of the original grant of 1,000,000 options to purchase vested on July 14, 2021, and one forty-eighth (1/48th) of the remaining options shall vest each month thereafter, in each case subject to continuous service of the Reporting Person through such date. |